To include your compound in the COVID-19 Resource Center, submit it here.

Ohana: Looking to the other half of reproductive biology

Ohana is applying single cell sequencing to the unexplored male half of reproductive biology

The latest newco to be unveiled by Flagship Pioneering, Ohana, is homing in on the unexplored side of reproductive science with its sperm biology platform designed to address reproductive health issues ranging from fertility to contraception.

Ohana Biosciences launched on Monday from Flagship Pioneering with undisclosed funding, a clinical candidate for assisted reproduction and a platform that focuses on treating the sperm, rather than the egg, for a suite of reproductive indications.

Read the full 724 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers